As of Feb 24
| +0.05 / +1.52%|
The 2 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 2.88, with a high estimate of 3.50 and a low estimate of 2.25. The median estimate represents a -13.66% decrease from the last price of 3.33.
The current consensus among 2 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.